ACTG 185

ACTG 185

AIDS Clinical Trial Group Study 185, Use of HIVIG for the Prevention of Maternal/Fetal HIV Transmission. A study that concluded that HIV hyperimmune globulin is ineffective in reducing the risk of perinatal HIV transmission in women with advanced HIV-related disease.